Pain Cloud®’s Post

**Plant-Based Success Stories: From Ancient Remedies to Cutting-Edge Discoveries** *Cancer Fighters: Plant-derived compounds like paclitaxel (Taxol) and vinblastine (Velban) are making a significant difference in cancer treatment. *Mental Health Breakthroughs: Research on plant-based psychedelics like psilocybin and ayahuasca shows promise in treating depression and anxiety. *Chronic Pain Relief: Plant-based compounds like CBD and THC have emerged as effective tool in managing chronic pain. As research delves deeper into the potential of plants, we can expect: *Increased Adoption: More healthcare professionals embracing plant-based solutions in their practices. *Innovative Products: A constant stream of new plant-based products and supplements hitting the market. *Powerful Collaborations: Interdisciplinary teams of plant scientists, healthcare professionals, and industry experts working together to unlock the full potential of plants. *Let's Cultivate a Healthier Future Together!* Join the movement! Share your thoughts, experiences, and questions about plant-based healthcare in the comments below. #PlantBased #Healthcare #PlantScience #Wellness #Phytotherapy #Phytomedicine #TraditionalMedicine #Innovation #Collaboration #Sustainability

The Ketamine Story from HubScience's Perspective Ketamine, initially developed as an anesthetic, has recently gained attention for its potential in treating mental health disorders, such as depression. Research into the effects of ketamine is an extremely intensive field, however, it remains a subject of controversy due to its misuse as a recreational drug. The story of ketamine took a tragic turn with the untimely passing of actor Matthew Perry, highlighting the fine line between therapeutic use and the dangers of substance abuse. By leveraging HubScience's capabilities, researchers can analyze the effect and dosage of subanesthetic ketamine, gaining insights into its potential as a rapid-acting antidepressant while exploring the broader implications of its pharmacological use. In one use case, we sought to answer two key questions: What subanesthetic doses were used for ketamine? and What kind of route of administration was used in previous studies?. After processing more than 300 relevant scientific publications with HubScience, the following results were obtained: The system automatically identified more than a thousand dose values related to ketamine. These included more than 135 different values. The majority of subanesthetic ketamine doses were in the range of 1-0.03 mg/kg in various in vivo models. The most frequently used subanesthetic dose was 0.05 mg/kg. HubScience also collected the delivery methods used for the doses used. In most cases, subanesthetic doses of ketamine were administered intravenously. During the preclinical studies, a single intraperitoneal sub-anesthetic ketamine was used at a dose of 10-15 mg/kg. This use case highlights HubScience helping researchers draw more informed conclusions from a vast body of scientific texts. To check out HubScience's features visit our website: hubscience.com #ResearchEfficiency, #ScientificLiteratureProcessing, #HubScience, #Ketamine

We’re excited to share that Scylex Lab, a leader in precision technology, research, and development, has officially joined the LinkedIn community! At Scylex Lab, we’re on a mission to revolutionize precision medicine by empowering healthcare providers and patients with genetically driven insights to optimize both medication and lifestyle choices. 🧬 What We Specialize In: #Pharmacogenomics (PGx) Our pharmacogenomic testing analyzes how your #genes influence drug metabolism, response, and side effects—allowing for personalized medication plans that are safer and more effective. #Nutrigenomics We examine how #genetics affect nutrient metabolism, absorption, and sensitivities, helping tailor nutrition and fitness strategies for optimal health and wellness. 🔄 The Synergy Through our research on the shared biological mechanisms of #nutrition, #medications, and #diseaserisk at the genetic level, we are building the foundation for a more comprehensive and personalized integrated approach. Why Choose Scylex Lab? ✔️ CLIA-certified lab using cutting-edge genomic sequencing technology ✔️ Comprehensive panels covering psychiatric medications, pain management, health & wellness genomics, and more ✔️ Trusted by healthcare providers for actionable, precision medicine insights ✔️ A dedicated R&D team continuously advancing the field of pharmacogenomics We’re thrilled to partner with healthcare providers, mental health professionals, and pharmacies to make precision medicine accessible and impactful for all. Let’s connect, collaborate, and transform healthcare—together!

Unlocking Pharmacogenomics 💊🧬 Your genes play a crucial role in how your body processes medications. 🧬💉 Pharmacogenomics (PGx) tailors treatments to your genetic profile, improving effectiveness and reducing side effects. 🌟 This breakthrough is transforming healthcare, offering more precise and personalised care. 🚀💪 Learn how PGx testing can optimise your treatment and help you take control of your healthcare journey. 🌱 👉 https://lnkd.in/dc-5gEzM #Pharmacogenomics #PersonalisedMedicine #HealthcareInnovation #GeneticTesting #PrecisionMedicine #HealthJourney #BetterCare #InnovationInMedicine #FutureOfHealthcare #ThoughtLeadershipThursday #AttoDiagnostics #HealthTech #SmartHealth #MedTech #WellnessJourney

𝗟𝗼𝘄 𝗙𝗹𝘂𝘅 𝗛𝗲𝗺𝗼𝗱𝗶𝗮𝗹𝘆𝘇𝗲𝗿 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟮: 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁. Our in-depth report offers a thorough examination of the Low Flux Hemodialyzer Market, incorporating both quantitative and qualitative data. Here's what you'll discover: Manufacturers: Gain a clear understanding of the competitive landscape and identify prominent players in the market. Regional Analysis: Make data-driven decisions by uncovering growth prospects across different regions. Types: Explore the various types of low flux hemodialyzers available, categorized by membrane material and surface area. Applications: Understand the diverse applications of low flux hemodialyzers, with a focus on their suitability for specific patient populations, such as those with hemodynamic instability or chronic illnesses. Empowering Informed Decisions for Dialysis Care Our report equips you with: Company Profiles: Get valuable insights into leading competitors, including product examples and market share estimates for 2024. Market Forecasts: Leverage segment-wise growth calculations and forecasts for consumption value from 2024 to 2032. This data empowers you to target specific market niches with high growth potential for maximized returns. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗟𝗼𝘄 𝗙𝗹𝘂𝘅 𝗛𝗲𝗺𝗼𝗱𝗶𝗮𝗹𝘆𝘇𝗲𝗿𝘀. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dhU9PgEa Market Segmentation *By Type: Our report explores different types of low flux hemodialyzers, categorized by membrane material (cellulose, modified cellulose) and surface area (low, medium, high). *By Application: We analyze the utilization of low flux hemodialyzers in various dialysis procedures, with a focus on their use for patients with hemodynamic instability, chronic illnesses, and those new to hemodialysis. Key Players in the Low Flux Hemodialyzer Market Fresenius Medical Care Baxter International Inc. Nipro Medical Corporation Asahi Kasei Bioprocess America, Inc. STADA Arzneimittel GmbH Johnstown Medical Centre Toray Medical Co.,Ltd. Nikkiso Cosmodyne EVEON #lowfluxhemodialyzer #hemodialysis #dialysis #renalcare #nephrology #chronic kidney disease #medicaldevices #medicaltechnology #artificialkidney #bloodfiltration #patientcare #dialysiscare #marketresearch #marketanalysis #healthcareinnovation #medicaleconomics

𝗟𝗼𝘄 𝗙𝗹𝘂𝘅 𝗛𝗲𝗺𝗼𝗱𝗶𝗮𝗹𝘆𝘇𝗲𝗿 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟮: 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁. Our in-depth report offers a thorough examination of the Low Flux Hemodialyzer Market, incorporating both quantitative and qualitative data. Here's what you'll discover: Manufacturers: Gain a clear understanding of the competitive landscape and identify prominent players in the market. Regional Analysis: Make data-driven decisions by uncovering growth prospects across different regions. Types: Explore the various types of low flux hemodialyzers available, categorized by membrane material and surface area. Applications: Understand the diverse applications of low flux hemodialyzers, with a focus on their suitability for specific patient populations, such as those with hemodynamic instability or chronic illnesses. Empowering Informed Decisions for Dialysis Care Our report equips you with: Company Profiles: Get valuable insights into leading competitors, including product examples and market share estimates for 2024. Market Forecasts: Leverage segment-wise growth calculations and forecasts for consumption value from 2024 to 2032. This data empowers you to target specific market niches with high growth potential for maximized returns. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗟𝗼𝘄 𝗙𝗹𝘂𝘅 𝗛𝗲𝗺𝗼𝗱𝗶𝗮𝗹𝘆𝘇𝗲𝗿𝘀. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dhU9PgEa Market Segmentation *By Type: Our report explores different types of low flux hemodialyzers, categorized by membrane material (cellulose, modified cellulose) and surface area (low, medium, high). *By Application: We analyze the utilization of low flux hemodialyzers in various dialysis procedures, with a focus on their use for patients with hemodynamic instability, chronic illnesses, and those new to hemodialysis. Key Players in the Low Flux Hemodialyzer Market Fresenius Medical Care Baxter International Inc. Nipro Medical Corporation Asahi Kasei Bioprocess America, Inc. STADA Arzneimittel GmbH Johnstown Medical Centre Toray Medical Co.,Ltd. Nikkiso Cosmodyne EVEON #lowfluxhemodialyzer #hemodialysis #dialysis #renalcare #nephrology #chronic kidney disease #medicaldevices #medicaltechnology #artificialkidney #bloodfiltration #patientcare #dialysiscare #marketresearch #marketanalysis #healthcareinnovation #medicaleconomics

𝗟𝗼𝘄 𝗙𝗹𝘂𝘅 𝗛𝗲𝗺𝗼𝗱𝗶𝗮𝗹𝘆𝘇𝗲𝗿 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟮: 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁. Our in-depth report offers a thorough examination of the Low Flux Hemodialyzer Market, incorporating both quantitative and qualitative data. Here's what you'll discover: Manufacturers: Gain a clear understanding of the competitive landscape and identify prominent players in the market. Regional Analysis: Make data-driven decisions by uncovering growth prospects across different regions. Types: Explore the various types of low flux hemodialyzers available, categorized by membrane material and surface area. Applications: Understand the diverse applications of low flux hemodialyzers, with a focus on their suitability for specific patient populations, such as those with hemodynamic instability or chronic illnesses. Empowering Informed Decisions for Dialysis Care Our report equips you with: Company Profiles: Get valuable insights into leading competitors, including product examples and market share estimates for 2024. Market Forecasts: Leverage segment-wise growth calculations and forecasts for consumption value from 2024 to 2032. This data empowers you to target specific market niches with high growth potential for maximized returns. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗟𝗼𝘄 𝗙𝗹𝘂𝘅 𝗛𝗲𝗺𝗼𝗱𝗶𝗮𝗹𝘆𝘇𝗲𝗿𝘀. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dhU9PgEa Market Segmentation *By Type: Our report explores different types of low flux hemodialyzers, categorized by membrane material (cellulose, modified cellulose) and surface area (low, medium, high). *By Application: We analyze the utilization of low flux hemodialyzers in various dialysis procedures, with a focus on their use for patients with hemodynamic instability, chronic illnesses, and those new to hemodialysis. Key Players in the Low Flux Hemodialyzer Market Fresenius Medical Care Baxter International Inc. Nipro Medical Corporation Asahi Kasei Bioprocess America, Inc. STADA Arzneimittel GmbH Johnstown Medical Centre Toray Medical Co.,Ltd. Nikkiso Cosmodyne EVEON #lowfluxhemodialyzer #hemodialysis #dialysis #renalcare #nephrology #chronic kidney disease #medicaldevices #medicaltechnology #artificialkidney #bloodfiltration #patientcare #dialysiscare #marketresearch #marketanalysis #healthcareinnovation #medicaleconomics